We are monitoring the impact of COVID-19 on Europe Digital Pathology Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 254
Share on
Share on

Europe Digital Pathology Market Research Report – Segmented By Type, By Product, By Application, By End User & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 254
Pages: 145

Europe Digital Pathology Market Size (2021 to 2026)

The Europe Digital Pathology Market size is estimated to grow USD 8.3 billion by 2026 from USD 54.8 million in 2021, registering a 10% CAGR from 2021 to 2026.

Digital pathology is defined as an image-based information environment for managing, analyzing, and interpreting the information achieved from a digital slide. In short, the digitalization of conventional pathology labs is referred to as digital pathology. This technology has gained momentum in the medical and healthcare industry. The improvements it brings in several applications include drug discoveries and their development, multi-functionalities in instruments, diagnostic tests, and other research applications.

MARKET DRIVERS:

An increasing number of cancer cases, the growing presence of teleconsultations, the high efficacy of digital pathology systems with increased adoption rate, and more initiatives undertaken by the government and private companies are majorly driving the European digital pathology market growth.

According to the World Health Organization, in 2018, Europe accounted for around 23.4% of global cases in Europe, and deaths are 20.3%, which is estimated to favor the European digital pathology market. It can boost cancer diagnosis fast. U.S. Food & Drug Administration approves the first digital pathology platform. It led to the rapid expansion of pathology tools with the application of digital pathology medicine.

On the other hand, barriers such as strict regulatory concerns for primary diagnosis, lack of standard guidelines for digital pathology, the nonexistence of reimbursement, and deficiency in skilled personnel are significant factors that are constraining the market in all likelihood.

MARKET RESTRAINTS:

The mounting requirement for sophisticated healthcare facilities, which can be met through establishing digital pathology systems, would offer lucrative opportunities for the service providers in the future if they can overcome threats like the high cost of installing new technology or building new infrastructure.

This research report on the European digital pathology market has been segmented and sub-segmented into the following categories:

By Type: 

  • Human Digital Pathology
  • Animal Digital Pathology

By Product: 

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems

By Application: 

  • Teleconsultation
  • Diseases Diagnosis
  • Drug Discovery
  • Training
  • Education

By End User: 

  • Pharmaceutical Companies
  • Hospitals
  • Academic Institutions

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European digital pathology market is expected to account for the second-largest share in the global digital pathology market during the forecast period. Primarily, the development is concentrated around western countries of the region where technological advancements can counter the temporary restraints resulting in a well-prospered market. Germany is the leading market in this geography, with a significant share in the forecast period.

The German digital pathology market is expected to play a leading role in the European market from 2021 to 2026. Germany is the third-largest market of healthcare devices worldwide. In Germany, there are particular guidelines of the professional Association of German Pathologists. It focuses on IT experts, Pathologists as well as a researchers about digital pathology to diagnosis. Germany owes not only digital pathology but also conventional pathology treatments for market growth. The IBM Corporation provides network services for the absolute result. It identifies the disease's pattern & stores that information, and this information helps the researcher innovate the new drug in the market. The German government provides funding for healthcare policies to healthcare devices.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the European digital pathology market profiled in this report are Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V., GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., Hamamatsu Photonics K.K., Digipath Co., ZEISS, Olympus Corporation, Yokogawa Electronics Corporation, and Quorum Technologies Inc.

Inspirata, Inc. acquired the digital pathology company Omnyx. The company delivered the primary diagnosis in Canada & Europe. This digital pathology improves cancer diagnostic. Omnyx is a software company. It provides software to the pathology department around the world. Ibex Medical Analytics and Medipath engage the strategic partnership with the usage of artificial intelligence. The Medipath is the largest network of private pathology in France. It empowers the accurate diagnosis. Alverno Laboratories have fully implemented digital pathology in clinical laboratories. Alverno laboratories network will use Phillips Intellisite Pathology solution.

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 By Type                                        

                                5.1.1 Human Digital Pathology                   

                                5.1.2 Animal Digital Pathology                    

                5.2 By Product                                  

                                5.2.1 Scanners                  

                                5.2.2 Software                  

                                5.2.3 Communication Systems                  

                                5.2.4 Storage Systems                   

                5.3 By Application                                           

                                5.3.1 Teleconsultation                   

                                5.3.2 Disease Diagnosis                 

                                5.3.3 Drug Discovery                      

                                5.3.4 Training and Education                       

                5.4 By End User                                

                                5.4.1 Pharmaceutical Companies                              

                                5.4.2 Hospitals                  

                                5.4.3 Academic Institutes                            

  1. Geographical Analysis

                                6.1 Introduction                               

                                6.2 U.K                 

                                6.3 France                          

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 Spain                             

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1. Perkin Elmer, Inc.                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2. Definiens AG                                            

                8.3. Sectra AB                                   

                8.4. Koninklijke Philips N.V                                          

                8.5. GE Healthcare                                          

                8.6. Inspirata Co.                                             

                8.7. Ventana Medical Systems, Inc.                                         

                8.8. Leica Biosystems                                     

                8.9. 3D-Histech Ltd                                         

                8.10. Hamamatsu Photonics, K.K.                                             

                8.11. Digipath Co.                                            

                8.12. ZEISS                                          

                8.13. Olympus Corporation                                         

                8.14. Yokogawa Electronic Corporation                                  

                8.15. Quorum Technologies Inc.                                               

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                          

a) List of Tables

b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Digital Pathology Market, By Region, From 2021 to 2026 (USD Billion)
  2. Europe Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  3. Europe Human Digital Pathology Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Animal Digital Pathology Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  6. Europe Scanners Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Software Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Communication Systems Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Storage Systems Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  11. Europe Teleconsultation Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Disease Diagnosis Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Training and Education Market, By Region, From 2021 to 2026 (USD Billion)
  15. Europe Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)
  16. Europe Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Billion)
  17. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  18. Europe Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  19. U.K. Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  20. U.K. Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  21. U.K. Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  22. U.K. Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)
  23. France Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  24. France Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  25. France Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  26. France Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)
  27. Germany Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  28. Germany Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  29. Germany Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  30. Germany Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)
  31. Italy Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  32. Italy Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  33. Italy Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  34. Italy Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)
  35. Spain Digital Pathology Market, By Type, From 2021 to 2026 (USD Billion)
  36. Spain Digital Pathology Market, By Product, From 2021 to 2026 (USD Billion)
  37. Spain Digital Pathology Market, By Application, From 2021 to 2026 (USD Billion)
  38. Spain Digital Pathology Market, By End user, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample